TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11068117

Group type: EXPERIMENTAL
Intervention: Pre-traumatic lidocaine infusion (30 min prior to heat trauma)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Post-traumatic lidocaine infusion (immediately after heat trauma)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no lidocaine)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Primary hyperalgesia (both pre- and post-traumatic lidocaine)
Number of subjects: 6
Study: 9414074

Group type: EXPERIMENTAL
Intervention: Heavy-resistance strength training
Number of subjects: 24
Study: 8338043

Group type: EXPERIMENTAL
Intervention: High-dose vitamin A supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (unsupplemented women)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CIC
Number of subjects: 0
Study: 2883920

Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg single dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg single dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg daily for three weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg daily for three weeks)
Number of subjects: 24
Study: 30465369

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion (300μg in 100ml over 3 minutes)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Haemocoel preload (500 ml before spinal anaesthesia)
Number of subjects: 90
Study: 26762672

Group type: EXPERIMENTAL
Intervention: PR-fampridine (10 mg, twice daily)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 24907876

Group type: EXPERIMENTAL
Intervention: Unilateral spinal anesthesia with 2.5 cm(3) of hyperbaric bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bilateral spinal anesthesia with 1.5 cm(3) of hyperbaric bupivacaine
Number of subjects: 0
Study: 22426704

Group type: EXPERIMENTAL
Intervention: Customized foot orthotics along with spinal exercise therapy and analgesics (Orthotics group)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Spinal exercise therapy and analgesics (Control group)
Number of subjects: 67
Study: 20637147

Group type: EXPERIMENTAL
Intervention: nSIMV
Number of subjects: 50

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 50
Study: 18356664

Group type: EXPERIMENTAL
Intervention: 4 peritumoral (PT) injections
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 1 subdermal (SD) injection of Tc‐99m rhenium sulfide colloid
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 1 PT and 1 SD combined injections
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 2 intradermal periareolar (ID‐PA) injections
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 2 ID‐PA and 1 PT combined injections
Number of subjects: 192

Group type: COMPARATOR
Intervention: PT and SD injection groups
Number of subjects: 192
Study: 15751813

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study: 12094339

Group type: COMPARATOR
Intervention: Cisplatin/paclitaxel
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Gemcitabine/cisplatin
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Gemcitabine/paclitaxel
Number of subjects: 480
Study: 10482007

Group type: EXPERIMENTAL
Intervention: Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clobetasol-17 propionate ointment without an HCD twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 0
Study: 8690806

Group type: EXPERIMENTAL
Intervention: Oral administration of bovine myelin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Nontreated patients
Number of subjects: 34
Study: 1480737

Group type: EXPERIMENTAL
Intervention: Lithium (daily doses ranged from 250 to 2100 mg)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91

Group type: COMPARATOR
Intervention: Lithium and Placebo
Number of subjects: 91
Study: 6238338

Group type: EXPERIMENTAL
Intervention: 70 mg paroxetine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31295048

Group type: EXPERIMENTAL
Intervention: Women who received ≥1 dose of HPV vaccine
Number of subjects: 3261

Group type: COMPARATOR
Intervention: Women who did not receive HPV vaccine (unvaccinated)
Number of subjects: 3261

Group type: EXPERIMENTAL
Intervention: Vaccinated women vs. unvaccinated women
Number of subjects: 3261

Group type: COMPARATOR
Intervention: Vaccinated mothers vs. unvaccinated mothers
Number of subjects: 3261
Study: 30275094

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 154
Study: 24685886

Group type: EXPERIMENTAL
Intervention: Irinotecan/Docetaxel (Arm A)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Irinotecan/Docetaxel/Cetuximab (Arm B)
Number of subjects: 87
Study: 23857741

Group type: EXPERIMENTAL
Intervention: Highest tertile of hs-CRP
Number of subjects: 2910

Group type: EXPERIMENTAL
Intervention: hs-CRP
Number of subjects: 2910
Study: 23427389

Group type: EXPERIMENTAL
Intervention: PKP plus Zishengukang (ZSGK) - 6 g orally three times a day for 90 days after PKP
Number of subjects: 70

Group type: COMPARATOR
Intervention: Percutaneous kyphoplasty (PKP) alone
Number of subjects: 70
Study: 20634962

Group type: EXPERIMENTAL
Intervention: Obstacle one (illusion made it appear larger)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: After 50 crossings
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: First five obstacle crossings (1-5)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Last five obstacle crossings (46-50)
Number of subjects: 50
Study: 18263771

Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticancer agents
Number of subjects: 0
Study: 16510370

Group type: EXPERIMENTAL
Intervention: Fluvastatin XL 80 mg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 94
Study: 15112850

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA) with isobaric 0.5% bupivacaine 3-3.5 ml intrathecally and 15 ml of bupivacaine with 1/200,000 epinephrine for wound infiltration
Number of subjects: 0

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 0
Study: 10703470

Group type: EXPERIMENTAL
Intervention: 14 G needle
Number of subjects: 100

Group type: COMPARATOR
Intervention: 12 G needle
Number of subjects: 100
Study: 8768637

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation with midazolam prior to surgery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation with midazolam until the end of surgery
Number of subjects: 30
Study: 1897688

Group type: EXPERIMENTAL
Intervention: L-648,051 (800 micrograms) inhaled during the immediate phase (15 min after antigen challenge)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-648,051 (800 micrograms) inhaled before antigen challenge (5 min before)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-648,051 (800 micrograms) inhaled before the expected late reaction (2.5 h after antigen challenge)
Number of subjects: 12
Study: 7212014

Group type: EXPERIMENTAL
Intervention: Lenses fitted 1 D flatter than 'K'
Number of subjects: 29

Group type: COMPARATOR
Intervention: Other treatment groups (not specified)
Number of subjects: 29
Study: 30859940

Group type: EXPERIMENTAL
Intervention: SPN-812 (100-400mg for children, 200-600mg for adolescents)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: SPN-812
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 28542611

Group type: EXPERIMENTAL
Intervention: ZIKV testing (plasma samples for ZIKV nucleic acid and antibodies)
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Euroimmun anti-Zika ELISA testing
Number of subjects: 1001
Study: 26616225

Group type: EXPERIMENTAL
Intervention: Veliparib (80mg p.o. b.i.d.) combined with PLD (30mg/m2, IV) and carboplatin (AUC 5, IV)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Veliparib (80mg p.o. b.i.d.) combined with PLD and carboplatin plus bevacizumab (10mg/kg on days 1 and 15)
Number of subjects: 39
Study: 24825530

Group type: EXPERIMENTAL
Intervention: Dexamethasone 40 mg (D40)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg (D8)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (D0)
Number of subjects: 101
Study: 22486858

Group type: EXPERIMENTAL
Intervention: Metformin in addition to peginterferon alfa‐2a and ribavirin
Number of subjects: 98
Study: 20390477

Group type: EXPERIMENTAL
Intervention: VCT-ID
Number of subjects: 301

Group type: COMPARATOR
Intervention: ID
Number of subjects: 301
Study: 17440005

Group type: EXPERIMENTAL
Intervention: Activation of ICD therapies for atrial tachyarrhythmia (AT)/atrial fibrillation (AF)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (deactivation of ICD therapies for AT/AF)
Number of subjects: 122
Study: 15738747

Group type: EXPERIMENTAL
Intervention: donepezil (5 mg, twice a day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo (twice a day)
Number of subjects: 26
Study: 11952104

Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 101
Study: 9472754

Group type: EXPERIMENTAL
Intervention: 8‐day course of 40 mg/day prednisone
Number of subjects: 15

Group type: COMPARATOR
Intervention: 8‐day tapering course of prednisone (tapering from 40 mg to 0 mg)
Number of subjects: 15
Study: 8598422

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (90 mg/day for 3 weeks)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 10
Study: 2686454

Group type: EXPERIMENTAL
Intervention: Tri‐Levlen
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Ortho‐Novum 7/7/7
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Tri‐Norinyl
Number of subjects: 206

Group type: COMPARATOR
Intervention: Nonhormonal forms of birth control
Number of subjects: 206
Study: 30256552

Group type: EXPERIMENTAL
Intervention: ALGOS (decision-making algorithm combining existing brief contact interventions)
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1040
Study: 28480661

Group type: EXPERIMENTAL
Intervention: Avanafil 50 mg
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Avanafil 100 mg
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Avanafil 200 mg
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 26037035

Group type: EXPERIMENTAL
Intervention: Intradermal (ID) bolus infusion of insulin aspart (NovoRapid U-100)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Subcutaneous (SC) bolus infusion of insulin aspart (NovoRapid U-100)
Number of subjects: 28
Study: 23278132

Group type: EXPERIMENTAL
Intervention: Diode Laser (DL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intense Pulsed Light (IPL)
Number of subjects: 30
Study: 20920848

Group type: EXPERIMENTAL
Intervention: Twice daily tobramycin and ceftazidime
Number of subjects: 146

Group type: COMPARATOR
Intervention: Three-times daily tobramycin and ceftazidime
Number of subjects: 146
Study: 19100416

Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii (T II) 1 mg/kg/d for 12 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Valsartan 80 mg twice per day for 12 months
Number of subjects: 36
Study: 16624683

Group type: EXPERIMENTAL
Intervention: Ventricular reconstruction
Number of subjects: 74

Group type: COMPARATOR
Intervention: Revascularization only
Number of subjects: 74
Study: 14560327

Group type: EXPERIMENTAL
Intervention: SR restoration and maintenance
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Increased left atrial area (<28 cm²)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Increase in fractional shortening of the left ventricle (range 25-40%)
Number of subjects: 205
Study: 11011878

Group type: EXPERIMENTAL
Intervention: Water exercise (70-min program: 10-min warm-up, 20-min brisk walking, 20-min rhythmic dancing, 10-min resistance training, 10-min cool down)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Land exercise (10-min warm-up, 30-min combined endurance and resistance exercise, 10-min cool down)
Number of subjects: 73
Study: 8793604

Group type: EXPERIMENTAL
Intervention: Pantoprazole 30 mg i.v. (acute study)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once-daily oral doses (chronic study)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no pantoprazole)
Number of subjects: 24
Study: 1618253

Group type: EXPERIMENTAL
Intervention: Salbutamol (4 micrograms.kg‐1.h‐1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 9
Study: 6432172

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Omeprazole 30 mg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Omeprazole 60 mg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 44
Study: 31498121

Group type: EXPERIMENTAL
Intervention: Teprenone (combined with donepezil)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (combined with donepezil)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Teprenone (combined with donepezil) in patients with mild atrophy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Teprenone (combined with donepezil) in patients with severe atrophy
Number of subjects: 79
Study: 30304302

Group type: EXPERIMENTAL
Intervention: Group Lavage (GL) with 10 ml of normal saline during vasectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group Without Lavage (GWL) receiving only vasectomy
Number of subjects: 60
Study: 26643851

Group type: EXPERIMENTAL
Intervention: Engagement in purposeful problem solving involving social science content
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observational learning (control group)
Number of subjects: 0
Study: 24673052

Group type: EXPERIMENTAL
Intervention: Acupuncture method of tonifying‐qi and dredging‐meridian
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional acupuncture method
Number of subjects: 70
Study: 23126260

Group type: EXPERIMENTAL
Intervention: True electroacupuncture
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham electroacupuncture (placebo)
Number of subjects: 31
Study: 20105039

Group type: EXPERIMENTAL
Intervention: Standard (ST) wave
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination (C) wave
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Square (SQ) wave
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Modified Combination (MC) wave
Number of subjects: 18
Study: 17622884

Group type: EXPERIMENTAL
Intervention: Oral fluconazole (400 mg loading dose followed by 200 mg QD for one week)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Parenteral fluconazole (400 mg loading dose followed by 200 mg QD for one week)
Number of subjects: 16
Study: 15866999

Group type: EXPERIMENTAL
Intervention: Antegrade sclerotherapy according to the Tauber procedure (group B)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open surgery (group A)
Number of subjects: 64
Study: 11995262

Group type: EXPERIMENTAL
Intervention: Triamcinolone (400 micrograms)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Montelukast (5 or 10 mg according to age)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Nedocromil (16 mg)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Formoterol (24 micrograms)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 9558432

Group type: EXPERIMENTAL
Intervention: Isoflurane 0.2%
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Isoflurane 0.6%
Number of subjects: 28
Study: 7604792

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Tolbutamide
Number of subjects: 48

Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fluvastatin or Simvastatin
Number of subjects: 48
Study: 2196121

Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Combination therapy (aminoglycoside, amoxicillin, clindamycin)
Number of subjects: 63
Study: 372823

Group type: EXPERIMENTAL
Intervention: Poly I:C immunotherapy
Number of subjects: 0
Study: 29848599

Group type: EXPERIMENTAL
Intervention: Unilateral TAP Group (Uni-TAP)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Bilateral TAP Group (Bi-TAP)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Local Anesthetic Infiltration (LAI) Group
Number of subjects: 69
Study: 28673814

Group type: EXPERIMENTAL
Intervention: Pressure-Regulated Volume-Controlled (PRVC) ventilation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Volume-Controlled ventilation
Number of subjects: 70
Study: 26188923

Group type: EXPERIMENTAL
Intervention: General practitioners (GP) managing iDDVT
Number of subjects: 167

Group type: COMPARATOR
Intervention: Vascular medicine physicians (VMP) managing iDDVT
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: General practitioners (GP) monitoring anticoagulation
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Intensity of anticoagulation
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Duration of anticoagulation by GP
Number of subjects: 167

Group type: COMPARATOR
Intervention: Duration of anticoagulation by VMP
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Treatment of iDDVT as long as proximal DVT by GP
Number of subjects: 167

Group type: COMPARATOR
Intervention: Treatment of iDDVT by VMP
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Therapeutic management comparison among GP
Number of subjects: 167
Study: 23471512

Group type: EXPERIMENTAL
Intervention: Deflated cuff
Number of subjects: 195

Group type: COMPARATOR
Intervention: Inflated cuff
Number of subjects: 195
Study: 21346689

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham procedure (control)
Number of subjects: 120
Study: 18499009

Group type: EXPERIMENTAL
Intervention: Cataract surgery before panretinal photocoagulation (surgery-first group)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Panretinal photocoagulation before cataract surgery (PRP-first group)
Number of subjects: 29
Study: 16358612

Group type: EXPERIMENTAL
Intervention: New treatment protocol for heart failure patients in general practice, based on many RCT's and reviews.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Co- and multi-medication in frail elderly patients.
Number of subjects: 0
Study: 12079900

Group type: EXPERIMENTAL
Intervention: Rheumatoid factors (RFs) measured by time resolved fluoroimmunoassay
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Disease activity parameters (ESR, CRP, tender joint score, swollen joint score)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Time integrated disease activity parameters
Number of subjects: 155
Study: 9549821

Group type: EXPERIMENTAL
Intervention: Growth curve model analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life data from a randomized trial
Number of subjects: 0
Study: 8778008

Group type: EXPERIMENTAL
Intervention: Women with prolapse of the genital organ
Number of subjects: 60

Group type: COMPARATOR
Intervention: Women with normal statics
Number of subjects: 60
Study: 2261821

Group type: EXPERIMENTAL
Intervention: Obesity (BMI >= 27 kg/m2 in men, >= 25 kg/m2 in women) and central obesity (waist-hip ratio >= 0.98 in men, >= 0.89 in women)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Combination of obesity and family history of diabetes
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Simultaneous presence of obesity, central obesity, and family history of diabetes
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Major risk factors for NIDDM (obesity, central fat distribution, family history of diabetes)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Prevalence rates of NIDDM and IGT
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Abnormal glucose tolerance according to WHO criteria
Number of subjects: 1300
Study: 753026

Group type: EXPERIMENTAL
Intervention: Estramustine and prednimustine combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednimustine alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crossover to estramustine after prednimustine therapy
Number of subjects: 0
Study: 31365315

Group type: EXPERIMENTAL
Intervention: Support for FGM among mothers
Number of subjects: 5048

Group type: EXPERIMENTAL
Intervention: Awareness of FGM's illegality among mothers
Number of subjects: 5048

Group type: EXPERIMENTAL
Intervention: Support for abandoning FGM among mullahs
Number of subjects: 5048

Group type: EXPERIMENTAL
Intervention: Support for abandoning FGM among mokhtars
Number of subjects: 5048

Group type: EXPERIMENTAL
Intervention: Support for FGM by maternal education level
Number of subjects: 5048

Group type: EXPERIMENTAL
Intervention: Prevalence of FGM among daughters
Number of subjects: 5048
Study: 28488685

Group type: EXPERIMENTAL
Intervention: Saturated Fatty Acids (SFA) diet
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: n-6 Polyunsaturated Fatty Acids (n-6PUFA) diet
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Long-chain n-3 Polyunsaturated Fatty Acids (LCn-3PUFA) supplementation
Number of subjects: 26
Study: 26252305

Group type: EXPERIMENTAL
Intervention: Heparin saline (HS) 50 U/mL
Number of subjects: 68

Group type: COMPARATOR
Intervention: Normal saline (NS) preservative-free 0.9% sodium chloride
Number of subjects: 68
Study: 24158326

Group type: EXPERIMENTAL
Intervention: Electrostimulator (ES) technique with 0.2 ml/kg (E1)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Electrostimulator (ES) technique with 0.6 ml/kg (E2)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Electrostimulator (ES) technique with 1.0 ml/kg (E3)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Blinded technique with 1.0 ml/kg (B4)
Number of subjects: 58
Study: 21266786

Group type: EXPERIMENTAL
Intervention: Intracoronary autologous freshly isolated bone marrow cells transplantation (BMCs‐Tx)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group without cell therapy
Number of subjects: 32
Study: 19012356

Group type: EXPERIMENTAL
Intervention: Celecoxib 3 mg/kg bid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib 6 mg/kg bid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen 7.5 mg/kg bid
Number of subjects: 0